Hemorrhagic cystitis after I.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer
Cantwell, B.M.; Harris, A.L.; Patrick, D.; Hall, R.R.
Cancer Treatment Reports 70(4): 548-549
1986
ISSN/ISBN: 0361-5960 PMID: 2421895 Document Number: 283236
Document emailed within 1 workday
Related Documents
Shoji, S.; Miyakita, H.; Shima, M.; Usui, Y.; Nagata, Y.; Uchida, T.; Terachi, T. 2006: Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer Hinyokika Kiyo. Acta Urologica Japonica 52(9): 723-726Mikami, K.; Nakagawa, S.; Sugimoto, K.; Nomoto, T.; Urano, S.; Watanabe, H.; Iwamoto, N.; Yamazaki, S.; Hiratake, Y.; Maegawa, M. 1997: Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria Hinyokika Kiyo. Acta Urologica Japonica 43(8): 561-566
Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Einhorn, L.H.; Williams, S.D. 1978: Combination chemotherapy with cis-dichlorodiammineplatinum(II) and adriamycin for testicular cancer refractory to vinblastine plus bleomycin Cancer Treatment Reports 62(9): 1351-1353
Bosl, G.J.; Kwong, R.; Lange, P.H.; Fraley, E.E.; Kennedy, B.J. 1980: Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer Cancer Treatment Reports 64(2-3): 331-334
Hainsworth, J.D.; Burnett, L.S.; Jones, H.W.; Greco, F.A. 1983: Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP) Cancer Treatment Reports 67(4): 393-395
Madej, G.; Zborzil, J.; Siedlecki, P. 1979: Results of chemotherapy with bleomycin and vinblastine of malignant testicular neoplasms at the Warsaw Institute of Oncology in the years 1977-1978 Polski Tygodnik Lekarski 34(47): 1821-1824
Von Eyben, F.E.; Jacobsen, G.K.; Pedersen, H.; Jacobsen, M.; Clausen, P.P.; Zibrandtsen, P.C.; Gullberg, B. 1982: Multivariate analysis of risk factors in patients with metastatic testicular germ cell tumors treated with vinblastine and bleomycin Invasion and Metastasis 2(2): 125-135
Angrilli, F.; Pennese, E.; Di Marzio, A.; Liberatore, E.; Di Lorenzo, R.; Fioritoni, G. 2002: A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma Haematologica 87(11): 1227-1229
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Kumano, M.; Miyake, H.; Hara, I.; Muramaki, M.; Takenaka, A.; Fujisawa, M. 2007: Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy Hinyokika Kiyo. Acta Urologica Japonica 53(12): 851-856
Pizzocaro, G.; Milani, A.; Piva, L.; Faustini, M.; Spino, E. 1991: Methotrexate, vinblastine, adriamycin and cisplatin versus methotrexate and cisplatin in advanced urothelial cancer. A randomized study European Urology 20(2): 89-92
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Tsujitani, S.; Watanabe, A.; Abe, Y.; Maehara, Y.; Sugimachi, K.; Kaibara, N. 1993: Intraperitoneal administration of cisplatin and etoposide during surgery for patients with gastric cancer Anticancer Research 13(6b): 2497-2499
Matsukado, Y.; Abe, H.; Tanaka, R.; Kobayashi, T.; Yamashita, J.; Nishimoto, A.; Ushio, Y.; Sato, K.; Matsutani, M.; Takakura, K. 1986: Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group Gan No Rinsho. Japan Journal of Cancer Clinics 32(11): 1387-1393
Rassweiler, J.; Rüther, U.; Bäuerle, K.; Bub, P.; Jipp, P.; Eisenberger, F. 1989: Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity Der Urologe. Ausg. a 28(1): 25-30
Thongprasert, S.; Chewaskulyong, B. 2004: Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer Journal of the Medical Association of Thailand 87(10): 1162-1167
Perez, E.A.; Gandara, D.R. 1994: Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 2-5